Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 366

1.

Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative.

Pan K, Nelson RA, Wactawski-Wende J, Lee DJ, Manson JE, Aragaki AK, Mortimer JE, Phillips LS, Rohan T, Ho GYF, Saquib N, Shadyab AH, Nassir R, Rhee JJ, Hurria A, Chlebowski RT.

J Natl Cancer Inst. 2019 Apr 26. pii: djz069. doi: 10.1093/jnci/djz069. [Epub ahead of print]

PMID:
31184362
2.

Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes.

Prentice RL, Aragaki AK, Howard BV, Chlebowski RT, Thomson CA, Van Horn L, Tinker LF, Manson JE, Anderson GL, Kuller LE, Neuhouser ML, Johnson KC, Snetselaar L, Rossouw JE.

J Nutr. 2019 Jun 8. pii: nxz107. doi: 10.1093/jn/nxz107. [Epub ahead of print]

PMID:
31175807
3.

Reply to F. Conforti et al.

Pan K, Bosserman L, Chlebowski RT.

J Clin Oncol. 2019 Jul 20;37(21):1840-1841. doi: 10.1200/JCO.19.01133. Epub 2019 Jun 7. No abstract available.

PMID:
31173556
4.

Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal women.

Pan K, Luo J, Aragaki AK, Chlebowski RT.

Oncotarget. 2019 May 3;10(33):3088-3092. doi: 10.18632/oncotarget.26864. eCollection 2019 May 3.

5.

Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Pan K, Bosserman LD, Chlebowski RT.

J Clin Oncol. 2019 Apr 10;37(11):858-861. doi: 10.1200/JCO.18.01360. Epub 2019 Feb 11. No abstract available.

PMID:
30742565
6.

Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.

Xu X, Chlebowski RT, Shi J, Barac A, Haque R.

Breast Cancer Res Treat. 2019 Apr;174(3):785-794. doi: 10.1007/s10549-018-05086-8. Epub 2019 Jan 18.

PMID:
30659431
7.

Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative.

Chlebowski RT, Mortimer JE, Crandall CJ, Pan K, Manson JE, Nelson R, Johnson KC, Vitolin MZ, Lane D, Wactawski-Wende J, Kwan K, Stefanick ML.

Menopause. 2018 Dec 28;26(6):578-587. doi: 10.1097/GME.0000000000001283.

PMID:
30601454
8.

Interaction of body mass index or waist-to-hip ratio and sun exposure associated with nonmelanoma skin cancer: A prospective study from the Women's Health Initiative.

Chan AA, Noguti J, Pak Y, Qi L, Caan B, Going S, Han J, Chlebowski RT, Lee DJ.

Cancer. 2019 Apr 1;125(7):1133-1142. doi: 10.1002/cncr.31810. Epub 2018 Dec 11.

PMID:
30548236
9.

Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.

Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ.

JAMA Oncol. 2018 Dec 6. doi: 10.1001/jamaoncol.2018.5327. [Epub ahead of print]

PMID:
30520976
10.

Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women.

Arthur R, Kabat GC, Kim MY, Ho GYF, Chlebowski RT, Pan K, Rohan TE.

Ann Epidemiol. 2019 Jan;29:23-29.e1. doi: 10.1016/j.annepidem.2018.09.005. Epub 2018 Sep 22.

PMID:
30449532
11.

Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women.

Haque R, Xu X, Shi J, Kwan ML, Chlebowski RT.

Ethn Dis. 2018 Oct 18;28(4):565-574. doi: 10.18865/ed.28.4.565. eCollection 2018 Fall.

12.

Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Chlebowski RT, Pan K.

N Engl J Med. 2018 Oct 25;379(17):1684. doi: 10.1056/NEJMc1810514. No abstract available.

PMID:
30358972
13.

Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial.

Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J.

Menopause. 2018 Nov;25(11):1313-1320. doi: 10.1097/GME.0000000000001235.

PMID:
30358728
14.

Notice of Retraction and Replacement. Tseng et al. Association of cataract surgery with mortality in older women: findings from the Women's Health Initiative. JAMA Ophthalmol. 2018;136(1):3-10.

Tseng VL, Chlebowski RT, Yu F, Cauley JA, Li W, Thomas F, Virnig BA, Coleman AL.

JAMA Ophthalmol. 2018 Nov 1;136(11):1313-1314. doi: 10.1001/jamaophthalmol.2018.3347. No abstract available.

PMID:
30352119
15.

Weight loss and breast cancer incidence in postmenopausal women.

Chlebowski RT, Luo J, Anderson GL, Barrington W, Reding K, Simon MS, Manson JE, Rohan TE, Wactawski-Wende J, Lane D, Strickler H, Mosaver-Rahmani Y, Freudenheim JL, Saquib N, Stefanick ML.

Cancer. 2019 Jan 15;125(2):205-212. doi: 10.1002/cncr.31687. Epub 2018 Oct 8.

PMID:
30294816
16.

Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?

Falk RT, Manson JE, Barnabei VM, Anderson GL, Brinton LA, Rohan TE, Cauley JA, Chen C, Coburn SB, Pfeiffer RM, Reding KW, Sarto GE, Wentzensen N, Chlebowski RT, Xu X, Trabert B.

Int J Cancer. 2019 Feb 15;144(4):730-740. doi: 10.1002/ijc.31851. Epub 2018 Nov 1.

PMID:
30183089
17.

Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.

Kwon GP, Gamba CS, Stefanick ML, Swetter SM, Li S, Shi RZ, Clarke CA, Feldman D, Millen AE, Messina C, Shikany JM, Manson JE, Chlebowski RT, Tang JY.

J Am Acad Dermatol. 2018 Jul;79(1):145-147. doi: 10.1016/j.jaad.2017.05.037. No abstract available.

PMID:
29908819
18.

Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women.

Banack HR, Stokes A, Fox MP, Hovey KM, Cespedes Feliciano EM, LeBlanc ES, Bird C, Caan BJ, Kroenke CH, Allison MA, Going SB, Snetselaar L, Cheng TD, Chlebowski RT, Stefanick ML, LaMonte MJ, Wactawski-Wende J.

Epidemiology. 2018 Sep;29(5):604-613. doi: 10.1097/EDE.0000000000000863.

PMID:
29864084
19.

Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL.

JAMA Oncol. 2018 Oct 1;4(10):e181212. doi: 10.1001/jamaoncol.2018.1212. Epub 2018 Oct 11. Erratum in: JAMA Oncol. 2019 Apr 1;5(4):580.

20.

Impact of hormone therapy on Medicare spending in the Women's Health Initiative randomized clinical trials.

Shreibati JB, Manson JE, Margolis KL, Chlebowski RT, Stefanick ML, Hlatky MA.

Am Heart J. 2018 Apr;198:108-114. doi: 10.1016/j.ahj.2017.12.016. Epub 2017 Dec 27.

21.

Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.

Kabat GC, Kim MY, Lane DS, Zaslavsky O, Ho GYF, Luo J, Nicholson WK, Chlebowski RT, Barrington WE, Vitolins MZ, Lin X, Liu S, Rohan TE.

Eur J Cancer Prev. 2018 May;27(3):261-268. doi: 10.1097/CEJ.0000000000000435.

PMID:
29438162
22.

Breast cancer survivorship: state of the science.

Pan K, Hurria A, Chlebowski RT.

Breast Cancer Res Treat. 2018 Apr;168(3):593-600. doi: 10.1007/s10549-017-4650-5. Epub 2018 Jan 13. Review.

PMID:
29332134
23.

Post-Stroke Cancer Risk among Postmenopausal Women: The Women's Health Initiative.

Sealy-Jefferson S, Cote ML, Chlebowski RT, Rexrode KM, Simon MS.

Womens Health Issues. 2018 Jan - Feb;28(1):29-34. doi: 10.1016/j.whi.2017.10.012. Epub 2017 Dec 2.

PMID:
29199053
24.

Serum lipids and risk of obesity-related cancers in postmenopausal women.

Kabat GC, Kim MY, Chlebowski RT, Vitolins MZ, Wassertheil-Smoller S, Rohan TE.

Cancer Causes Control. 2018 Jan;29(1):13-24. doi: 10.1007/s10552-017-0991-y. Epub 2017 Dec 2.

PMID:
29197994
25.

Complexity of intermittent letrozole adjuvant therapy.

Chlebowski RT, Pan K.

Lancet Oncol. 2018 Jan;19(1):13-15. doi: 10.1016/S1470-2045(17)30854-9. Epub 2017 Nov 17. No abstract available.

PMID:
29158010
26.

Intentional weight loss and cancer risk.

Luo J, Hendryx M, Chlebowski RT.

Oncotarget. 2017 Sep 6;8(47):81719-81720. doi: 10.18632/oncotarget.20671. eCollection 2017 Oct 10. No abstract available.

27.

Association of Cataract Surgery With Mortality in Older Women: Findings from the Women's Health Initiative.

Tseng VL, Chlebowski RT, Yu F, Cauley JA, Li W, Thomas F, Virnig BA, Coleman AL.

JAMA Ophthalmol. 2018 Jan 1;136(1):3-10. doi: 10.1001/jamaophthalmol.2017.4512.

28.

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.

Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, Manson JE, Chlebowski RT, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1730-1735. doi: 10.1158/1055-9965.EPI-17-0495. Epub 2017 Sep 22.

29.

Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.

Park NJ, Chang Y, Bender C, Conley Y, Chlebowski RT, van Londen GJ, Foraker R, Wassertheil-Smoller S, Stefanick ML, Kuller LH.

PLoS One. 2017 Sep 21;12(9):e0184174. doi: 10.1371/journal.pone.0184174. eCollection 2017.

30.

Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.

Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, Richardson P, Lane D, Sangi-Haghpeykar H, El-Serag HB.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx117.

31.

Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.

Cheng TD, Song X, Beresford SAA, Ho GYF, Johnson KC, Datta M, Chlebowski RT, Wactawski-Wende J, Qi L, Neuhouser ML.

Cancer Causes Control. 2017 Oct;28(10):1053-1063. doi: 10.1007/s10552-017-0956-1. Epub 2017 Sep 12.

32.

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.

Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J; WHI Investigators.

JAMA. 2017 Sep 12;318(10):927-938. doi: 10.1001/jama.2017.11217.

33.

Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative.

Cespedes Feliciano EM, Prentice RL, Aragaki AK, Neuhouser ML, Banack HR, Kroenke CH, Ho GYF, Zaslavsky O, Strickler HD, Cheng TD, Chlebowski RT, Saquib N, Nassir R, Anderson G, Caan BJ.

Int J Cancer. 2017 Dec 1;141(11):2281-2290. doi: 10.1002/ijc.30931. Epub 2017 Aug 31.

34.

Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health Initiative.

Thomson CA, Crane TE, Garcia DO, Wertheim BC, Hingle M, Snetselaar L, Datta M, Rohan T, LeBlanc E, Chlebowski RT, Qi L.

J Acad Nutr Diet. 2018 Apr;118(4):617-626. doi: 10.1016/j.jand.2017.06.010. Epub 2017 Aug 17.

35.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.

Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, Shifren J, Chen C, Kaunitz AM, Cauley JA, Manson JE.

Menopause. 2018 Jan;25(1):11-20. doi: 10.1097/GME.0000000000000956.

36.

Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.

Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, Margolis KL, Qi L, Reding KW, Shields PG, Simon MS, Wactawski-Wende J, Wang A, Womack C, Manson JE.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1345-1348. doi: 10.1158/1055-9965.EPI-17-0096.

37.

Erratum to: Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures.

Kabat GC, Xue X, Kamensky V, Lane D, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE.

Cancer Causes Control. 2017 Sep;28(9):1007-1009. doi: 10.1007/s10552-017-0931-x. No abstract available.

PMID:
28752192
38.

Emerging combination endocrine therapies for advanced breast cancer.

Pan K, Lin EM, Chlebowski RT.

Breast J. 2018 Mar;24(2):214-215. doi: 10.1111/tbj.12876. Epub 2017 Jul 26. No abstract available.

PMID:
28744960
39.

Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, Manson JE, Simon MS, Howard BV, Rohan TE, Snetselar L, Lane D, Barrington W, Vitolins MZ, Womack C, Qi L, Hou L, Thomas F, Prentice RL.

J Clin Oncol. 2017 Sep 1;35(25):2919-2926. doi: 10.1200/JCO.2016.72.0326. Epub 2017 Jun 27.

40.

Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.

Drieling RL, LaCroix AZ, Beresford SAA, Boudreau DM, Kooperberg C, Chlebowski RT, Ko MG, Heckbert SR.

J Am Geriatr Soc. 2017 Sep;65(9):1924-1931. doi: 10.1111/jgs.14911. Epub 2017 May 29.

41.

Effect of depression before breast cancer diagnosis on mortality among postmenopausal women.

Liang X, Margolis KL, Hendryx M, Reeves K, Wassertheil-Smoller S, Weitlauf J, Danhauer SC, Chlebowski RT, Caan B, Qi L, Lane D, Lavasani S, Luo J.

Cancer. 2017 Aug 15;123(16):3107-3115. doi: 10.1002/cncr.30688. Epub 2017 Apr 7.

42.

Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.

Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, Kim E, Yaffe MD, Boyd NF, Heiss G, McTiernan A, Chlebowski RT, Lane DS, Manson JE, Wactawski-Wende J, Pisano ED.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.

43.

Response.

Chlebowski RT, Pan K, Nananda F.

Breast Cancer Res Treat. 2017 Jun;163(3):633-634. doi: 10.1007/s10549-017-4197-5. Epub 2017 Mar 28. No abstract available.

PMID:
28353060
44.

Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).

Cauley JA, Danielson ME, Jammy GR, Bauer DC, Jackson R, Wactawski-Wende J, Chlebowski RT, Ensrud KE, Boudreau R.

J Clin Endocrinol Metab. 2017 May 1;102(5):1538-1547. doi: 10.1210/jc.2016-3589.

45.

Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies.

Yu D, Takata Y, Smith-Warner SA, Blot W, Sawada N, White E, Freedman N, Robien K, Giovannucci E, Zhang X, Park Y, Gao YT, Chlebowski RT, Langhammer A, Yang G, Severi G, Manjer J, Khaw KT, Weiderpass E, Liao LM, Caporaso N, Krokstad S, Hveem K, Sinha R, Ziegler R, Tsugane S, Xiang YB, Johansson M, Zheng W, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1060-1070. doi: 10.1158/1055-9965.EPI-16-0863. Epub 2017 Mar 6.

46.

Intentional Weight Loss and Endometrial Cancer Risk.

Luo J, Chlebowski RT, Hendryx M, Rohan T, Wactawski-Wende J, Thomson CA, Felix AS, Chen C, Barrington W, Coday M, Stefanick M, LeBlanc E, Margolis KL.

J Clin Oncol. 2017 Apr 10;35(11):1189-1193. doi: 10.1200/JCO.2016.70.5822. Epub 2017 Feb 6.

47.

Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer: Results from the Women's Health Initiative.

Arem H, Pfeiffer RM, Moore SC, Irwin ML, LaMonte MJ, Sarto GE, Nassir R, Luo J, Chlebowski RT, Brinton LA, Matthews CE.

PLoS One. 2017 Feb 2;12(2):e0171250. doi: 10.1371/journal.pone.0171250. eCollection 2017.

48.

Improving Breast Cancer Risk Assessment Versus Implementing Breast Cancer Prevention.

Chlebowski RT.

J Clin Oncol. 2017 Mar;35(7):702-704. doi: 10.1200/JCO.2016.70.9386. Epub 2016 Dec 28. No abstract available.

PMID:
28029306
49.

Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.

Banegas MP, John EM, Slattery ML, Gomez SL, Yu M, LaCroix AZ, Pee D, Chlebowski RT, Hines LM, Thompson CA, Gail MH.

J Natl Cancer Inst. 2016 Dec 20;109(2). doi: 10.1093/jnci/djw215. Print 2017 Feb.

50.

Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.

Wang A, Aragaki AK, Tang JY, Kurian AW, Manson JE, Chlebowski RT, Simon M, Desai P, Wassertheil-Smoller S, Liu S, Kritchevsky S, Wakelee HA, Stefanick ML.

Br J Cancer. 2017 Jan;116(3):e2. doi: 10.1038/bjc.2016.396. Epub 2016 Dec 6. No abstract available.

Supplemental Content

Loading ...
Support Center